Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China flag China · Delayed Price · Currency is CNY
28.76
+0.75 (2.68%)
Sep 21, 2026, 3:00 PM CST

SHA:603882 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
101.76-173.24-381.24643.382,7552,220
Depreciation & Amortization
362.65404.59554.03571528.4425.98
Other Amortization
93.8498.1298.4107.5790.46107.99
Loss (Gain) From Sale of Assets
-5.4-4.4-6.36-2.2-3.999.74
Asset Writedown & Restructuring Costs
12.1212.63149.969.771.020.37
Loss (Gain) From Sale of Investments
8.71-0.21140.82-262.9710.87.29
Provision & Write-off of Bad Debts
59.96369.89618.94488.41255.3171.09
Other Operating Activities
40.919.82-15.0214.13105.32172.8
Change in Accounts Receivable
592.3742.6263.521,247-2,702-2,116
Change in Inventory
4.812.2149.89157.42-58.82-107.02
Change in Accounts Payable
-143.32-193.55-413.54-1,633891.851,162
Change in Other Net Operating Assets
-6.5--33.19-40.89102.14133.14
Operating Cash Flow
1,0941,202906.351,2311,9482,088
Operating Cash Flow Growth
-10.50%32.62%-26.36%-36.81%-6.71%37.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-451.54-423.46-446.36-714.75-840.54-952.42
Sale of Property, Plant & Equipment
20.2819.6315.218.9420.3773.23
Cash Acquisitions
----6.7-22.09-
Divestitures
---218.03--
Investment in Securities
24.4821.72-25.88-150.29-8.52-131.98
Other Investing Activities
14.4811.131.510.232.411.55
Investing Cash Flow
-392.3-370.97-455.53-634.53-848.37-1,010

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-221.89368.84206.2680-
Long-Term Debt Repaid
--181.96-219.76-330.43-295.51-187.63
Lease Payments
-87.96-94.47-121.13-126.34-116.36-105.9
Net Debt Issued (Repaid)
-6.3239.93149.08-124.16-215.51-187.63
Issuance of Common Stock
---41.7636.63342.13
Repurchase of Common Stock
-173.44--210-89.99--
Common Dividends Paid
-415.82-413.9-419.57-839.33-609.52-169.98
Other Financing Activities
-18.19-20.23-8.31-50.29-80.17-37.54
Financing Cash Flow
-613.77-394.2-488.8-1,062-868.57-53.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-25.69-13.5510.837.3938.95-11.46
Net Cash Flow
62.4423.28-27.15-458.34269.861,014

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
642.62778.55459.99516.071,1071,136
Free Cash Flow Growth
-20.63%69.26%-10.87%-53.39%-2.49%16.77%
Free Cash Flow Margin
10.86%12.91%6.40%6.04%7.16%9.51%
Free Cash Flow Per Share
1.381.660.991.112.372.44
Levered Free Cash Flow
535.98852.16530.61292.07284.4502.44
Unlevered Free Cash Flow
544.02861.34542.13304.82299.18519.66
Free Cash Flow After Leases
554.66684.09338.85389.74990.951,030

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
123.0279.71182.67392.94587.14294.69
Change in Working Capital
419.6484.82-253.18-338.27-1,794-926.93